Dentists in Leesport, PA Accepting Medicare
4 Dentists found. Showing 1 - 4
 Dr. Laura Snyder, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1001 James Dr, Suite A-10, Leesport, PA 19533 Phone: 610-916-7600 Fax: 610-916-7601 |
Dr. Kristin Anne Lawler Gordos, D.M.D. Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 1001 James Dr., Suite A-10, Leesport, PA 19533 Phone: 610-916-7600 Fax: 610-916-7601 |
 Dr. Jordan David Hottenstein, D.M.D Dentist - General Practice Medicare: Medicare Enrolled Practice Location: First And Peach Streets, Leesport, PA 19533 Phone: 610-926-5705 Fax: 610-926-6446 |
Dr. Agnieszka Magdalena Radwan-woch, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1001 James Dr, B33, Leesport, PA 19533 Phone: 610-916-2700 Fax: 610-916-2701 |
News Archive
Artificial intelligence can help accurately predict acute kidney injury in burn patients
Many burn victims suffer acute kidney injury (AKI), but early recognition of AKI remains challenging. Now an Artificial Intelligence / Machine Learning (AI/ML) model developed at UC Davis Health and reported in a new study can predict acute kidney injury quicker and more accurately than ever.
Metformin therapy improves BMI and fasting glucose levels in obese children
Metformin therapy has a beneficial treatment effect over placebo in improving body mass index (BMI) and fasting glucose levels in obese children, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). The study showed reduction in BMI was sustained for six months.
DePuy Synthes Companies, AO Foundation sign cooperation agreement to improve patient outcomes
The DePuy Synthes Companies of Johnson & Johnson today announced that the company has signed a five-year cooperation agreement with the AO Foundation to continue the work they began together in 1960 to deliver world-class professional education and develop new innovations that improve patient outcomes and increase efficiency of care.
ADC Therapeutics, Five Prime sign exclusive license agreement for human antibodies
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 6 days ago
Occupational Therapists
Counselors
Pharmacists
Dentists
Psychologists
Clinical Social Workers